We are live on
!
Find out more
NICM
Neo Ivy Capital Management Portfolio holdings
AUM
$379M
1-Year Est. Return
28.34%
This Fund
S&P 500
This Quarter
Est. Return
-0.94%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$153M
AUM Growth
-$24.5M
(-14%)
Cap. Flow
-$18.4M
Cap. Flow
% of AUM
-12.05%
Top 10 Holdings %
Top 10 Hldgs %
8.41%
Holding
442
New
184
Increased
47
Reduced
40
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Resources
BEN
|
+$1.49M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.44M |
| 3 |
AGNC Investment
AGNC
|
+$1.41M |
| 4 |
Synchrony
SYF
|
+$1.38M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$1.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.47M |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.45M |
| 3 |
AT&T
T
|
+$1.45M |
| 4 |
Intuit
INTU
|
+$1.45M |
| 5 |
Truist Financial
TFC
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.39% |
| 2 | Technology | 13.83% |
| 3 | Industrials | 12.5% |
| 4 | Financials | 12.34% |
| 5 | Healthcare | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Red Rock Resorts
RRR
$3.58B
| $33K | 0.02% |
+1,604
| New | +$33.5K |
|
|
252
Bristol-Myers Squibb
BMY
$132B
| $30K | 0.02% |
621
-31,329
| -98% | -$1.47M |
|
253
Meritage Homes
MTH
$4.69B
| $28K | 0.02% |
+842
| New | +$26.3K |
|
254
Associated Banc-Corp
ASB
$5.92B
| $23K | 0.02% |
1,203
-7,377
| -86% | -$149K |
|
255
Boston Scientific
BSX
$73.1B
| $22K | 0.01% |
+525
| New | +$22.2K |
|
256
Healthpeak Properties
DOC
$14.4B
| $19K | 0.01% |
+548
| New | +$18.5K |
|
257
Outfront Media
OUT
$5.29B
| $18K | 0.01% |
+663
| New | +$17.7K |
|
258
Freeport-McMoran
FCX
$98.7B
| $16K | 0.01% |
+1,698
| New | +$17.4K |
|
259
Clorox
CLX
$13B
| $13K | 0.01% |
+84
| New | +$13.3K |
|
260
CVB Financial
CVBF
$3.97B
| $9K | 0.01% |
+437
| New | +$9.14K |
|
|
DHC
261
Diversified Healthcare Trust
DHC
$2.04B
| $9K | 0.01% |
+1,109
| New | +$9.56K |
|
262
Fulton Financial
FULT
$4.6B
| $7K | ﹤0.01% |
417
-31,482
| -99% | -$512K |
|
263
Old National Bancorp
ONB
$10.1B
| $6K | ﹤0.01% |
+330
| New | +$5.63K |
|
264
CVS Health
CVS
$122B
| $5K | ﹤0.01% |
+90
| New | +$5.33K |
|
265
Kennametal
KMT
$2.41B
| $5K | ﹤0.01% |
+164
| New | +$5.23K |
|
266
United Rentals
URI
$70.8B
| $5K | ﹤0.01% |
+45
| New | +$5.46K |
|
|
WRI
267
DELISTED
Weingarten Realty Investors
WRI
| $5K | ﹤0.01% |
+183
| New | +$5.05K |
|
|
DOC
268
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $4K | ﹤0.01% |
225
-35,547
| -99% | -$617K |
|
269
Home BancShares
HOMB
$6.17B
| $3K | ﹤0.01% |
+151
| New | +$2.82K |
|
270
Timken Company
TKR
$8.77B
| $2K | ﹤0.01% |
+50
| New | +$2.21K |
|
271
Ingersoll Rand
IR
$33.6B
| $1K | ﹤0.01% |
+35
| New | +$1.08K |
|
272
Alcoa
AA
$13.6B
| – | – |
-28,508
| Closed | -$667K |
|
273
AbbVie
ABBV
$438B
| – | – |
-3,214
| Closed | -$234K |
|
274
Acadia Pharmaceuticals
ACAD
$5.06B
| – | – |
-16,832
| Closed | -$450K |
|
275
Accenture
ACN
$109B
| – | – |
-7,830
| Closed | -$1.45M |
|
Similar funds
KFS
MC
ACA
AFCM
DAL
SFWC
WAM
FP
Neo Ivy Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Neo Ivy Capital Management held 442 positions worth $153M, down 14% from $177M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Neo Ivy Capital Management withdrew a net $18.4M in Q3 2019, closing 171 positions and reducing 40 holdings. Its most notable exit was Tableau Software, Inc., an estimated $1.45M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
Against the trend, Neo Ivy Capital Management opened a new position in Franklin Resources worth $1.28M.
- Neo Ivy Capital Management's largest Q3 2019 buy was Franklin Resources: 48,716 shares worth $1.28M.
- Neo Ivy Capital Management added most to RETAIL PROPERTIES OF AMERICA, INC. in Q3 2019, an estimated $1.31M increase.
- Neo Ivy Capital Management's biggest Q3 2019 reduction was Bristol-Myers Squibb, cutting an estimated $1.47M.
- Neo Ivy Capital Management fully exited Tableau Software, Inc. in Q3 2019, selling an estimated $1.45M.
- Neo Ivy Capital Management's ten largest holdings make up 8.4% of its $153M portfolio in Q3 2019.
- Neo Ivy Capital Management opened 184 new positions and closed 171 in Q3 2019.
- Neo Ivy Capital Management's portfolio value fell 14% quarter-over-quarter to $153M.
Based on Neo Ivy Capital Management's 13F filing for Q3 2019, filed 21 Nov 2019.